Proton magnetic resonance spectroscopy of the anterior cingulate gyrus, insular cortex and thalamus in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome)

Journal of Psychiatry and Neuroscience

Volumn 30, Issue 6, 2005, Pages 416-422

  Yasukawa, Rei ^a   Miyaoka, Tsuyoshi ^a   Mizuno, Shoichi ^a   Inagaki, Takuji ^a   Horiguchi, Jun ^a   Oda, Kazushige ^a   Kitagaki, Hajime ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Anterior cingulate gyrus; Gilbert disease; Hyperbilirubinemia; Insular cortex; Proton magnetic resonance spectroscopy; Schizophrenia; Thalamus

Indexed keywords

CREATINE PHOSPHATE; CREATININE; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; FEMALE; GILBERT DISEASE; HUMAN; INSULA; MALE; PROTON NUCLEAR MAGNETIC RESONANCE; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; THALAMUS;

ADULT; ASPARTIC ACID; CEREBRAL CORTEX; CHOLINE; FEMALE; GILBERT DISEASE; GYRUS CINGULI; HUMANS; INOSITOL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; SCHIZOPHRENIA; THALAMUS;

EID: 29144464751     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Owens D, Evans J. Population studies on Gilbert's syndrome. J Med Genet 1975;12:152-6.
2. Adachi Y, Nanno T, Yamamoto T. [Japanese clinical statistical data of patients with constitutional jaundice.] Nippon Rinsho 1992;50 Suppl:677-85.
3. Gilbert A, Lereboullet P. La cholermie simple familiale. Semaine Med 1901;21:241-5.
4. Shapiro SM. Bilirubin toxicity in the developing nervous system. Pediatr Neurol 2003;29:410-21.
5. Weinberger D. Schizophrenia, from neuropathology to neurodevelopment. Lancet 1995;346:552-7.
6. Muller N, Schiller P, Ackenheil M. Coincidence of schizophrenia and hyperbilirubinemia. Pharmacopsychiatry 1991;24:225-8.
7. Miyaoka T, Seno H, Itoga M, Maeda T, Horiguchi J. Schizophrenia- associated idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome): three case reports. J Clin Psychiatry 2000;61:299-300.
8. Miyaoka T, Seno H, Itoga M, Iijima M, Inagaki T, Horiguchi J. Schizophrenia-associated idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). J Clin Psychiatry 2000;61:868-71.
9. Miyaoka T, Seno H, Itoga M, Inagaki T, Horiguchi J. Structural brain changes in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome): a planimetric CT study. Schizophr Res 2001;52:291-3.
10. Dalman C, Cullberg J. Neonatal hyperbilirubinemia - a vulnerability factor for mental disorder? Acta Psychiatr Scand 1999;100:469-71.
11. Miyaoka T, Yasukawa R, Mizuno S, Sukegawa T, Inagaki T, Horiguchi J. Clinical features of schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). Int Psych Clin Pract 2003;7:199-203.
12. Menon DK, Baudouin CJ, Tomlinso D, Hoyle C. Proton MR spectroscopy and imaging of the brain in AIDS: evidence of neuronal loss in regions that appear normal with imaging. J Comput Assist Tomogr 1990;14:882-5.
13. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry 1990;47(11):1023-8.
14. Andreasen NC, Arndt S, Swayze V 2nd, Cizadlo T, Flaum M, O'Leary D, et al. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science 1994;266:294-8.
15. Charles HC, Lazeyras F, Krishnan KR, Boylo OB, Patterson LJ, Doraiswamy PM, et al. Proton spectroscopy of human brain: effects of age and sex. Prog Neuropsychopharmacol Biol Psychiatry 1994;18:995-1004.
16. Bertolino A, Nawroz S, Mattay VS, Barnett AS, Duyn JH, Moonen CT, et al. Regional specific neuronal pathology in untreated patients with schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry 1996;153:1554-63.
17. Fukuzako H, Hashiguchi T, Sakamoto Y, Okamura H, Doi W, Takenouchi K, et al. Metabolite changes with age measured by proton magnetic resonance spectroscopy in normal subjects. Psychiatry Clin Neurosci 1997;51:261-3.
18. Omori M, Pearce J, Komoroski RA, Griffin ST, Mrak RE, Husain MM, et al. In vitro 1H-magnetic resonance spectroscopy of postmortem brain with schizophrenia. Biol Psychiatry 1997;42:359-66.
19. Otsuka H, Harada M, Mori K, Hisaoka S, Nishitani H. Brain metabolites in the hippocampus-amygdala region and cerebellum in autism: an 1H-MR spectroscopy study. Neuroradiology 1999;41:517-9.
20. Deicken RF, Johnson C, Eliaz Y, Schuff N. Reduced concentrations of thalamic N-acetyl-aspartate in male patients with schizophrenia. Am J Psychiatry 2000;157:644-7.
21. Kegeles LS, Shungu DC, Anjivel S, Chan S, Ellis SP, Xanthopoulos E, et al. Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies. Psychiatry Res 2000;98:163-75.
22. Miyaoka T, Yasukawa R, Mizuno S, Sukegawa T, Inagaki J, Horiguchi J, et al. Proton magnetic resonance spectroscopy (1H-MRS) of hippocampus, basal ganglia, and vermis of cerebellum in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). J Psychiatr Res 2005;39:29-34.
23. Ostrow JD, Pascolo L, Brites D, Tiribelli C. Molecular basis of bilirubin-induced neurotoxicity. Trends Mol Med 2004;10:65-70.
24. Miyaoka T, Yasukawa R, Mizuno S, Mihara T, Sukegawa T, Uegaki J, et al. Fluid-attenuated inversion-recovery MR imaging in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). Eur Psychiatry. 2005;20:327-31.
25. Yamasue H, Fukui T, Fukuda R, Yamada H, Yamasaki S, Kuroki N, et al. 1H-MR spectroscopy and gray matter volume of the anterior cingulate cotex in schizophrenia. Neuroreport 2002;13:2133-7.
26. Crespo-Facorro B, Kim J, Andreasen NC, O'Leavy DS, Bockholt HJ, Magnotta V. Insular cortex abnormalities in schizophrenia: a structural magnetic resonance imaging study of first-episode patients. Schizophr Res 2000;46:35-43.
27. Omori M, Murata T, Kimura H, Koshimoto Y, Kado H, Ishimori Y, et al. Thalamic abnormalities in patients with schizophrenia revealed by proton magnetic resonance spectroscopy. Psychiatry Res 2000;98:155-62.
28. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed. Washington: the Association; 1994.
29. Overall JE, Gorham DE. The brief psychiatric rating scale. Psychol Rep 1962;10:799-812.
30. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-76.
31. Spitzer R, Williams J, Gibbon M, First M. Structured clinical interview for DSM III-R (SCID-P, version 1.0). Washington: American Psychiatric Press; 1990.
32. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971;9:97-113.
33. Delamillieure P, Constans JM, Fernandez J, Brazo P, Benail K, Courtheoux P, et al. Proton magnetic resonance spectroscopy (1H-MRS) in schizophrenia: investigation of the right and left hippocampus, thalamus, and prefrontal cortex. Schizophr Bull 2002;28:329-39.
34. Webb PG, Sailasuta N, Kohler SJ, Raidy T, Moats RA, Hurd RE. Automated single-voxel proton MRS; technical development and multisite verification. Magn Reson Med 1994;31:365-73.
35. Kreis R, Ernst T, Ross BD. Absolute quantitation of water and metabolites in human brain II. Metabolite concentrations. J Magn Reson B 1993;102:9-19.
36. Ende G, Braus DF, Walter S, Henn FA. Lower concentration of thalamic N-acetylaspartate in patients with schizophrenia: a replication study. Am J Psychiatry 2001;158:1314-6.
37. Ende G, Braus DF, Walter S, Weber FW, Henn FA. Multiregional 1H-MRSI of the hippocampus, thalamus, and basal ganglia in schizophrenia. Eur Arch Psychiatry Clin Neurosci 2003;253:9-15.
38. Théberge J, Bartha R, Drost DJ, Menon RS, Malla A, Takhar J, et al. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. Am J Psychiatry 2002;159:1944-6.
39. Sawasaki Y, Yamada N, Nakajima H. Developmental features of cerebellar hypoplasia and brain bilirubin levels in a mutant (Gunn) rat with hereditary hyperbilirubinemia. J Neurochem 1976;27:577-83.
40. Conlee JW, Shapiro SM, Churn SB. Expression of the a and b sub-units of Ca2+/calmodulin kinase II in the cerebellum of jaundiced Gunn rats during development: a quantitative light microscopic analysis. Acta Neuropathol (Berl) 2000;99:393-401.
41. McDonald JW, Shapiro SM, Silverstein FS, Johnston MV. Role of glutamate receptor-mediated excitotoxicity in bilirubin-induced brain injury in the Gunn rat model. Exp Neurol 1998;150:21-9.
42. Lim KO, Adalsteinsson E, Spielman D, Sullivan EV, Rosenbloom MJ. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Arch Gen Psychiatry 1998;55:346-52.